Answer
Tezspire (tezepelumab) is contraindicated in people with hypersensitivity to tezepelumab or any excipient listed in section 6.1.
Sources for this answer
- Tezspire 210 mg solution for injection in pre-filled syringeAstraZeneca UK Limited · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked